The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease

The growing prevalence and progression of chronic kidney disease (CKD) raises concerns about our capacity to manage its economic burden to patients, caregivers, and society. The societal direct and indirect costs of CKD and end-stage renal disease are substantial and increase throughout disease prog...

Full description

Saved in:
Bibliographic Details
Published inSeminars in nephrology Vol. 36; no. 4; p. 319
Main Authors Wang, Virginia, Vilme, Helene, Maciejewski, Matthew L, Boulware, L Ebony
Format Journal Article
LanguageEnglish
Published United States 01.07.2016
Subjects
Absenteeism
Disease Progression
Efficiency
Health Care Costs
Humans
Kidney Failure, Chronic - economics
Mortality, Premature
Presenteeism - economics
Renal Insufficiency, Chronic - economics
costs
economics
Chronic kidney disease
end-stage renal disease
Online AccessGet more information

Cover

More Information
Summary:The growing prevalence and progression of chronic kidney disease (CKD) raises concerns about our capacity to manage its economic burden to patients, caregivers, and society. The societal direct and indirect costs of CKD and end-stage renal disease are substantial and increase throughout disease progression. There is significant variability in the evidence about direct and indirect costs attributable to CKD and end-stage renal disease, with the most complete evidence concentrated on direct health care costs of patients with advanced to end-stage CKD. There are substantial gaps in evidence that need to be filled to inform clinical practice and policy.
ISSN:1558-4488
DOI:10.1016/j.semnephrol.2016.05.008